Doctiplus - We are allways here!
Heart Disease & Cardiovascular
Weekly Report
- 103 new clinical trials registered across 10 countries.
- 8,764 trials actively recruiting patients worldwide.
- Notable trial: AI-based Decision Support in Acute Chest Pain (4500 patients).
- 1,223 new research papers published.
- Drug safety: Most reported effect across tracked medications (atorvastatin, lisinopril, metoprolol, amlodipine, warfarin) was Fatigue.
- No active drug recalls for tracked medications this week.
The week in numbers
Trials by country
Trials by phase
New clinical trials registered this week for Heart Disease & Cardiovascular. Each trial links to its full record on ClinicalTrials.gov where you can find eligibility criteria, locations, and contact information.
This week's new registrations
103 trials registered for Heart Disease & Cardiovascular. Each links to its full record on ClinicalTrials.gov.
| # | Trial ↓ | Phase ↕ | Status ↕ | Enrollment ↕ | Country ↕ |
|---|---|---|---|---|---|
| 01 | Effectiveness of Digital Cardiac Rehabilitation on Functional Capacity in Patients With Myocardial Infarction Heart Disease & Cardiovascular · Cairo University (NCT07867197) | Other | Recruiting | 60 | Egypt |
| 02 | Biomarker Testing to Predict Radiation-Related Heart Disease in Lung Cancer Patients Heart Disease & Cardiovascular · Duke University (NCT07869329) | Other | Not Yet Recruiting | 50 | United States |
| 03 | Volution of Pulmonary Artery Dimensions in Tetralogy of Fallot Heart Disease & Cardiovascular · University Hospital, Strasbourg, France (NCT07864129) | Other | Recruiting | 400 | France |
| 04 | Cardiovascular History and Hemodynamic Complications After Intubation in ICU Heart Disease & Cardiovascular · University Hospital, Strasbourg, France (NCT07864259) | Other | Recruiting | 160 | France |
| 05 | Post-exercise Blood Pressure With Inorganic Nitrate Heart Disease & Cardiovascular · University of Virginia (NCT07869472) | Other | Not Yet Recruiting | 12 | United States |
| 06 | Visual Impairment and Functional Visual Performance Following Acquired Brain Injury: A Cross-Sectional Study Heart Disease & Cardiovascular · Charles University, Czech Republic (NCT07858708) | Other | Enrolling By Invitation | 108 | Czechia |
| 07 | Instructor Interpersonal Behaviours in Classical Pilates as a Pathway to Improve Blood Pressure Control and Well-being in Hypertensive Adults Heart Disease & Cardiovascular · Instituto Politécnico de Leiria (NCT07860437) | Other | Not Yet Recruiting | 96 | Portugal |
| 08 | Barber and Pharmacist Coordination to Improve Blood Pressure Management Heart Disease & Cardiovascular · Cedars-Sinai Medical Center (NCT07858695) | Other | Not Yet Recruiting | 55 | United States |
| 09 | Hemodynamic Characteristics of Peripheral Arterial Disease Using Computational Fluid Dynamics Heart Disease & Cardiovascular · Fudan University (NCT07860138) | Other | Not Yet Recruiting | 14 | China |
| 10 | PhiCube for Bilateral Upper Limb Neuromotor and Cognitive Rehabilitation in Adults Heart Disease & Cardiovascular · Istituto di Sistemi e Tecnologie Industriali Intelligenti per il Manifatturiero Avanzato (NCT07865260) | Other | Not Yet Recruiting | 80 | Italy |
| 11 | Dexmedetomidine vs Propofol Sedation in Endovascular Aortic Repair Heart Disease & Cardiovascular · Bursa City Hospital (NCT07857005) | Other | Completed | 282 | Turkey (Türkiye) |
| 12 | Medical Management vs Partial Revascularization in Diffuse Multivessel Coronary Artery Disease Heart Disease & Cardiovascular · CH. Pervaiz Elahi Institute of Cardiology, Multan (NCT07866404) | Other | Active Not Recruiting | 140 | Pakistan |
| 13 | Multimodal Approach Feasability Study for Untreated and Unruptured Intracranial Aneurysms Heart Disease & Cardiovascular · Resolve Stroke (NCT07864389) | Other | Not Yet Recruiting | 15 | N/A |
| 14 | Inspiratory Muscle Strength Training in Adults With Type 1 Diabetes Heart Disease & Cardiovascular · Florida State University (NCT07859943) | Other | Not Yet Recruiting | 30 | United States |
| 15 | UltraTrac Clinical Pilot Study Heart Disease & Cardiovascular · AcQumen Medical, Inc. (NCT07864714) | Other | Not Yet Recruiting | 50 | United States |
| 16 | A Prospective, Multicenter, Single-Arm Trial of Peripheral Vein Thrombectomy Stent System in Deep Venous Thrombosis Heart Disease & Cardiovascular · Shanghai TENDFO Medical Technology Co., Ltd. (NCT07857850) | Other | Completed | 132 | China |
| 17 | EDAS Revascularization for Symptomatic Intracranial Atherosclerotic Steno-occlusive Disease, Phase IIb Heart Disease & Cardiovascular · Cedars-Sinai Medical Center (NCT07864649) | Other | Not Yet Recruiting | 170 | N/A |
| 18 | Accelerated (Intensive) Cardiac Training for Heart Failure Patients Heart Disease & Cardiovascular · Washington University School of Medicine (NCT07858318) | Other | Not Yet Recruiting | 20 | N/A |
| 19 | Cryoballoon Pulmonary Vein Isolation for Paroxysmal Atrial Fibrillation Heart Disease & Cardiovascular · Shenyang Northern Hospital (NCT07862972) | Other | Not Yet Recruiting | 50 | China |
| 20 | Nutritional Assessment in Children With Cardiomyopathy Heart Disease & Cardiovascular · Assiut University (NCT07858474) | Other | Not Yet Recruiting | 108 | N/A |
| 21 | The CLASP III TR CED Study Heart Disease & Cardiovascular · Edwards Lifesciences (NCT07859709) | Other | Not Yet Recruiting | 2,350 | United States |
| 22 | Continuous Delivery of Ranibizumab Via the Port Delivery System for Proliferative Diabetic Retinopathy-related Vitreous Hemorrhage With Pars Plana Vitrectomy and Limited PRP. Heart Disease & Cardiovascular · Southeast Retina Center, Georgia (NCT07864480) | Phase 4 | Not Yet Recruiting | 20 | United States |
| 23 | Functional Outcomes in Patients With Cerebral Infarction After Aquatic Physiotherapy and Aerobic Exercise Heart Disease & Cardiovascular · Lithuanian University of Health Sciences (NCT07861009) | Other | Not Yet Recruiting | 40 | Lithuania |
| 24 | PrEcision Pacing in HFpEF: the PEP-HFpEF Trial Heart Disease & Cardiovascular · Tufts Medical Center (NCT07864558) | Other | Not Yet Recruiting | 36 | United States |
| 25 | Tissue Validation of Mammographic Breast Arterial Calcification in Mastectomy Specimens (SIDEMARA) Heart Disease & Cardiovascular · Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital (NCT07865884) | Other | Not Yet Recruiting | 100 | N/A |
| 26 | The Influence of the Thoracic Stiffness of CPR Teaching Manikins on the Accuracy of Compression in Cardiopulmonary Resuscitation Heart Disease & Cardiovascular · Tang Ziren (NCT07861841) | Other | Completed | 183 | China |
| 27 | Efficacy and Safety of the Angionix Balloon in Patients With Coronary Artery Disease Undergoing PTCA Heart Disease & Cardiovascular · Yonsei University (NCT07869602) | Other | Not Yet Recruiting | 600 | South Korea |
| 28 | Hyperoxemia and Oxygen Reserve Index During Neurointerventional Anesthesia Heart Disease & Cardiovascular · Fatih Sultan Mehmet Training and Research Hospital (NCT07859982) | Other | Not Yet Recruiting | 100 | Turkey (Türkiye) |
| 29 | Effect of Omega 3 Fatty Acids on Heart and Liver in Beta Thalassemia Patients Heart Disease & Cardiovascular · Ain Shams University (NCT07863791) | Phase 2 | Completed | 100 | Egypt |
| 30 | Multi-center Research Clinical Trial Protocol for Etiology-pathology and Repair Classification of Mitral and Tricuspid Valves Heart Disease & Cardiovascular · Keli Huang (NCT07863531) | Other | Not Yet Recruiting | 200 | N/A |
| 31 | A Study to Evaluate COR-2003 as Monotherapy and Co-Administered With COR-1004 in Adult Volunteers Heart Disease & Cardiovascular · Corsera Health (NCT07858019) | Phase 1 | Not Yet Recruiting | 108 | Australia |
| 32 | Serum Endogenous Estrogens, Estrogen Receptors, and Sirtuin-1 and -3 After Resveratrol Supplementation Heart Disease & Cardiovascular · InCor Heart Institute (NCT07865377) | Other | Recruiting | 80 | Brazil |
| 33 | AI-Based Conversational Social Support for Older Adults With Heart Failure Heart Disease & Cardiovascular · Chang Gung University of Science and Technology (NCT07862933) | Other | Recruiting | 174 | Taiwan |
| 34 | CArdiovascular Phenotyping in Recreationally Active Saudi Women Heart Disease & Cardiovascular · Imam Abdulrahman Bin Faisal University (NCT07861893) | Other | Enrolling By Invitation | 240 | Saudi Arabia |
| 35 | TRiP-cast Score Validation and Evaluation of Adherence to Preventive Anticoagulant Treatment in Patients With Lower Limb Trauma Requiring Immobilization Heart Disease & Cardiovascular · University of Monastir (NCT07863115) | Other | Recruiting | 1,500 | Tunisia |
| 36 | Stellate Ganglion Neuromodulation for the Treatment of Electrical Storm Heart Disease & Cardiovascular · Population Health Research Institute (NCT07857889) | Other | Not Yet Recruiting | 300 | Canada |
| 37 | This Will be a Randomized Comparison of the Proteomic Effects of Vicadrostat/Empagliflozin Versus Empagliflozin and Versus Empagliflozin/Spironolactone in Heart Failure Patients With Preserved Ejection Fraction Heart Disease & Cardiovascular · Baim Institute for Clinical Research (NCT07857772) | Phase 2 | Not Yet Recruiting | 200 | N/A |
| 38 | Rhythmic Auditory Stimulation in Heart Failure Patients Heart Disease & Cardiovascular · Necmettin Erbakan University (NCT07864363) | Other | Active Not Recruiting | 40 | Turkey (Türkiye) |
| 39 | AI-based Decision Support in Acute Chest Pain Heart Disease & Cardiovascular · Region Skane (NCT07864038) | Other | Not Yet Recruiting | 4,500 | N/A |
| 40 | Coronary Sinus Reducer Objective Impact on SymptoMs, Ischaemia and miCrovascular Resistance in Non-obstructive Hypertrophic CardioMyopathy Heart Disease & Cardiovascular · Imperial College London (NCT07865364) | Other | Not Yet Recruiting | 50 | United Kingdom |
| 41 | Cardiovascular Safety of Atomoxetine in Children With ADHD Heart Disease & Cardiovascular · Assiut University (NCT07858448) | Other | Not Yet Recruiting | 82 | N/A |
| 42 | Immune Responses and Pulmonary Complications After Cardiac Surgery With Cardiopulmonary Bypass Heart Disease & Cardiovascular · Assistance Publique - Hôpitaux de Paris (NCT07865533) | Other | Not Yet Recruiting | 100 | France |
| 43 | Role of Postpartum Furosemide in Recovery of Patients With Severe Preeclampsia Heart Disease & Cardiovascular · Lady Reading Hospital, Pakistan (NCT07861685) | Other | Recruiting | 434 | Pakistan |
| 44 | EXIT-CVD Project: Evidence Based Exit Strategies for the Cardiovascular Disease Continuum Trough Early Detection, Treatment and Evaluation Heart Disease & Cardiovascular · Centro Cardiologico Monzino (NCT07857031) | Other | Active Not Recruiting | 300 | Italy |
| 45 | Predicting Plaque Growth Using Blood Flow Stress Markers: A Proof-of-Concept Study Heart Disease & Cardiovascular · Queen Mary University of London (NCT07864051) | Other | Recruiting | 270 | United Kingdom |
| 46 | UltraTrac for Cardiac Output Monitoring in Congenital Heart Disease Heart Disease & Cardiovascular · University of Minnesota (NCT07866573) | Other | Not Yet Recruiting | 70 | United States |
| 47 | Virtual Reality During Coronary Angiography Heart Disease & Cardiovascular · Karamanoğlu Mehmetbey University (NCT07860268) | Other | Completed | 62 | Turkey (Türkiye) |
| 48 | Physical Activity and Functional Capacity in Patients With Congenital Long QT Syndrome Heart Disease & Cardiovascular · University of Sao Paulo (NCT07862491) | Other | Not Yet Recruiting | 120 | Brazil |
| 49 | Elevated Midline Positioning During Diaper Change in Preterm Infants Heart Disease & Cardiovascular · Akdeniz University (NCT07865897) | Other | Not Yet Recruiting | 80 | N/A |
| 50 | Prediction of Adverse Events From Non-PCI Coronary Plaques Using Machine Learning Heart Disease & Cardiovascular · A.O.U. Città della Salute e della Scienza (NCT07866144) | Other | Completed | 600 | Italy |
Adverse event reports
Adverse drug event reports compiled from the FDA's FAERS database for medications commonly prescribed for Heart Disease & Cardiovascular. These reports reflect what patients and healthcare providers have reported — they do not confirm a drug caused the effect.
Reports by drug
| Drug | Top effect | Count |
|---|---|---|
| atorvastatin | Fatigue | 1,084 |
| lisinopril | Fatigue | 1,493 |
| metoprolol | Fatigue | 1,783 |
| amlodipine | Fatigue | 2,132 |
| warfarin | Off Label Use | 239 |
Recalls & safety notices
FDA drug recall notices for medications related to Heart Disease & Cardiovascular. If your medication is listed, contact your pharmacist or visit fda.gov/safety/recalls for guidance. No recall listed does not guarantee safety — always consult your healthcare provider.
No active drug recalls for tracked medications this period.
Published research
Recently published peer-reviewed studies related to Heart Disease & Cardiovascular, sourced from PubMed and Semantic Scholar. Click any title to read the full paper, or expand the abstract for a quick summary.
| # | Study | Journal | Date | Source |
|---|---|---|---|---|
| 01 |
Bimekizumab efficacy across GRAPPA domains to 3 years in patients with psoriatic arthritis: a post hoc analysis of two phase 3 studies.
View abstractOBJECTIVES: To evaluate the long-term efficacy of bimekizumab in patients with psoriatic arthritis (PsA) across the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) domains, PsA-related conditions, and comorbidities. METHODS: Post hoc analysis of pooled data from BE OPTIMAL (NCT03895203; biologic-naïve patients) and BE COMPLETE (NCT03896581; patients with prior inadequate response/intolerance to tumour necrosis factor inhibitors) phase 3 studies, and their open-label extension BE VITAL (NCT04009499), which assessed subcutaneous bimekizumab 160 mg every 4 weeks in patients with active PsA. Efficacy was assessed to 3 years (Week 148) across GRAPPA core domains, PsA-related conditions (inflammatory bowel disease [IBD] and uveitis), and inflammatory markers of cardiovascular risk. RESULTS: Among 1,112 bimekizumab-treated patients with PsA, improvements were sustained across the GRAPPA core domains to 3 years. Resolution of swollen and tender joint count at 3 years was achieved by 59.2% and 34.6% of patients, respectively, while 54.8% achieved ≥50% improvement from baseline in American College of Rheumatology response criteria (modified non-responder imputation [mNRI]). Enthesitis (LEI=0) and dactylitis (LDI=0) resolution was also achieved by 56.6% (mNRI) and 68.6% (NRI) of patients, respectively. A high proportion of patients achieved skin and nail psoriasis clearance (PASI100: 64.6%; mNAPSI=0: 68.0%; mNRI). IBD and uveitis events were rare, and inflammatory cardiovascular risk marker improvements were sustained. CONCLUSION: Bimekizumab provided long-term, sustained disease control across GRAPPA domains and systemic inflammation markers in patients with PsA, with low rates of IBD and uveitis, supporting its use as a long-term treatment for the heterogeneous manifestations of PsA. CLINICAL TRIAL REGISTRATION: BE OPTIMAL: NCT03895203; BE COMPLETE: NCT03896581; BE VITAL: NCT04009499. |
Rheumatology (Oxford, England) | 2026 Oct 10 | PubMed |
| 02 | Serial multidomain six-minute walk assessment for dynamic risk prediction in idiopathic pulmonary fibrosis. | American journal of respiratory and critical care medicine | 2026 Oct 10 | PubMed |
| 03 |
Prominent V Waves Augment Right Ventricular Afterload Independent of the Lung Vessels in Heart Failure: Implications for Clinical Assessment of Pulmonary Vascular Disease.
View abstractBACKGROUND: Left atrial (LA) stiffening augments the LA V wave, pressurizing the pulmonary artery (PA) out of proportion to left ventricular end-diastolic pressure. We characterized the pathophysiologic, diagnostic, and clinical implications of LA stiffening, as defined by prominent V waves, in heart failure with preserved ejection fraction. METHODS: In this retrospective cohort study, patients with heart failure with preserved ejection fraction and less than moderate mitral regurgitation at rest underwent invasive hemodynamic exercise testing. Patients with heightened operant LA stiffening were defined by the PA wedge pressure (PAWP) V wave exceeding mean PAWP by ≥10 mm Hg. A previously used formula for V wave-corrected PAWP was validated against the PAWP waveform pressure-time-area to explore impact of the V wave on transpulmonary pressure gradients. Clinical, echocardiographic, hemodynamic, and outcome data were compared for patients with and without prominent V waves. RESULTS: Compared with patients without prominent V waves (n=844, 79%), those with prominent V waves (n=225, 21%) were older and more likely to be women, with more severe LA myopathy, evidenced by greater LA volume index (42.2±15.0 versus 32.5±13.0 mL/m, <0.001), lower LA reservoir strain (16.4±7.5% versus 23.2±8.3%, <0.001), more atrial fibrillation (61.3% versus 22.9%, <0.001), and increased operant LA reservoir stiffness (0.59±0.25 versus 0.23±0.24 mm Hg/mL, <0.001). Patients with prominent V waves had markedly higher PA systolic pressure than those without (54±16 versus 38±12 mm Hg, <0.001) despite no difference in end-diastolic PAWP-PA pressure gradient (3±5 versus 3±4 mm Hg, =0.950). Incorporating the V wave into PAWP improved correlation between directly measured PAWP pressure-time integral compared with mid-A wave PAWP (R=0.96 versus R=0.86, <0.001 for comparison). In patients with prominent V waves, the prevalence of combined pre- and postcapillary pulmonary hypertension decreased from 60.2% to 29.3% after V wave correction for the transpulmonary pressure gradients. Despite similar corrected pulmonary vascular resistances in patients with and without prominent V waves, apparent PA compliance was much lower in patients with prominent V waves (3.03±1.56 versus 4.90±2.27 mL/mm Hg, <0.001), augmenting right ventricular afterload, and these changes were coupled with more severe right ventricular dysfunction, tricuspid regurgitation, blunted cardiopulmonary exercise reserve, and increased risk of hospitalization for heart failure or death in patients with versus without prominent V waves (adjusted hazard ratio, 2.09 [95% CI, 1.53-2.86]; <0.001). CONCLUSIONS: More than 1 in 5 patients with heart failure with preserved ejection fraction display prominent V waves in excess of end-diastolic PAWP. This augments right ventricular afterload due to backward transmission of the V wave, contributing to right heart failure that is independent of the pulmonary vasculature. Failure to account for the V wave during hemodynamic assessment overestimates the severity of pulmonary vascular disease present. |
Circulation | 2026 Oct 11 | PubMed |
| 04 | Clarifying the Clinical Relevance of V Waves. | Circulation | 2026 Oct 11 | PubMed |
| 05 |
Cardiometabolic disease burden and first health-related cessation of work among middle-aged Chinese adults: a longitudinal competing-exit study.
View abstractOBJECTIVES: To examine whether a time-updated count of physician-diagnosed cardiometabolic conditions is associated with first survey-reported health-related cessation of work among adults in China. METHODS: We analyzed 4,404 participants aged 45-60 years working and neither formally retired nor reporting baseline health-related work disruption in the China Health and Retirement Longitudinal Study. Across three intervals from 2011 to 2018, the exposure was the lagged, time-updated count of physician-diagnosed hypertension, diabetes, heart disease, stroke, and kidney disease. The outcome was first health-related work exit, with retirement, other exit, and death as competing states. The primary association was estimated with discrete-time cause-specific pooled logistic regression, participant-clustered standard errors, and 50 longitudinal imputations. RESULTS: The cohort contributed 10,852 observed person-periods and 346 health-related work exits. Each additional diagnosed cardiometabolic condition was associated with higher odds of health-related work exit after adjustment for interval, age, sex, education, work type, smoking, alcohol, and body mass index (odds ratio 1.73, 95% confidence interval 1.51-1.97). Estimates were similar across clustering, weighting, and other sensitivity analyses. By Wave 4, standardized cumulative incidence was 6.4%, 10.5%, and 16.6% for condition counts 0, 1, and 2. CONCLUSIONS: A higher count of physician-diagnosed cardiometabolic conditions was prospectively associated with first survey-reported health-related cessation of work, although residual confounding by unmeasured socioeconomic and job-demand factors cannot be excluded. Replication with adjudicated employment outcomes and cross-cohort validation is needed before policy or causal interpretation. |
Journal of occupational health | 2026 Oct 11 | PubMed |
| 06 |
Changes in Lead Parameters of Cardiac Implantable Electronic Devices After VT/VF Ablation Using a Dual-Energy Lattice-Tip Catheter.
View abstractBACKGROUND: Interactions between cardiac implantable electronic devices (CIEDs) and pulsed field ablation (PFA) have been studied mainly in the context of atrial ablation, whereas the effects of ventricular ablation using a dual-energy lattice-tip catheter on ventricular leads remain unclear. METHODS: This retrospective study involved 79 patients (mean age 60.9 ± 13.6 years) with an implantable cardioverter-defibrillator or cardiac resynchronization therapy defibrillator who underwent ventricular ablation using a lattice-tip catheter between February 2024 and November 2025. Pacing thresholds were assessed before, immediately after, and 3 months after ablation and standardized to a pulse width of 0.4 ms using the Lapicque-Weiss model. Marked acute threshold elevation was defined as an increase in pacing threshold of ≥ 1.0 V immediately after ablation. The anatomical relationship between ablation sites and ventricular lead locations was assessed based on the American Heart Association 17-segment model of the left ventricle and classified as corresponding when ablation involved the same or opposing ventricular region as the lead location, adjacent when ablation involved a directly adjacent region, and remote otherwise. RESULTS: Marked acute pacing-threshold elevation occurred in 5 of 79 right ventricular (RV) leads (6.3%) and 2 of 22 evaluable left ventricular (LV) leads (9.1%). For RV leads, marked threshold elevation occurred in 4 of 14 patients (28.6%) in the corresponding group, 1 of 19 (5.3%) in the adjacent group, and none of 46 (0%) in the remote group. When threshold change was analyzed as a continuous variable, the acute increase was significantly greater in the corresponding group (+ 0.74 V; 95%CI 0.465-1.018) than in the adjacent (+ 0.31 V; 95%CI 0.076-0.550) and remote (+ 0.007 V; 95%CI - 0.145-0.160) groups. For LV leads, the pacing threshold increased significantly after ablation involving the corresponding segment (+ 0.71 V; 95%CI 0.167-1.245), although the overall association between anatomical relationship and threshold change was not significant. At 3 months, pacing thresholds in the corresponding groups were not significantly different from baseline for either RV or LV leads. CONCLUSION: Marked acute pacing-threshold elevation was observed in both RV and LV leads after ventricular arrhythmia ablation using a dual-energy lattice-tip catheter. However, both RV and LV thresholds were no longer significantly different from baseline at 3 months. These findings suggest the importance of considering the anatomical relationship between ablation sites and CIED leads and of careful peri-procedural assessment of lead function during ventricular ablation. |
Journal of cardiovascular electrophysiology | 2026 Oct 11 | PubMed |
| 07 |
[Principles of treating patients with chronic obstructive pulmonary disease].
View abstractChronic obstructive pulmonary disease (COPD) is a heterogeneous condition characterized by inflammation of the airways and lung parenchyma, manifested by persistent respiratory symptoms such as dyspnoe and cough. As a global pandemic, it affects approximately 10.3% of the population over the age of 40 and remains among the leading causes of death with an increasing mortality trend. In Hungary, the estimated actual prevalence is approximately three times higher than the number of officially registered cases. COPD imposes a significant economic burden, primarily driven by the hospital care required for acute exacerbations. The systemic consequences of chronic inflammation contribute to the development of frequent comorbidities, such as atherosclerosis and heart failure. The primary objectives in managing stable COPD are symptom reduction, improvement of quality of life, and the prevention of disease progression. The cornerstones of therapy include smoking cessation, maintenance inhalation pharmacotherapy, and various non-pharmacological interventions. The latter encompasses appropriately indicated pulmonary rehabilitation, long-term oxygen therapy, and non-invasive ventilation, as well as lung volume reduction interventions and lung transplantation in selected cases. The selection of optimal, individualized therapy combined with high patient adherence significantly improves survival rates. Orv Hetil. 2026; 167(41): 1639-1645. |
Orvosi hetilap | 2026 Oct 11 | PubMed |
| 08 |
[Successful treatment of hypokalemic cardiac arrest with massive potassium replacement in a patient with Bricker urinary diversion].
View abstractSevere hypokalemia is a rare but potentially reversible cause of malignant arrhythmias and cardiac arrest. Early recognition of significant fluid, electrolyte, and acid-base disturbances in patients with intestinal urinary diversion may be life-saving. We present the clinical course of a 55-year-old woman who developed severe hyperchloremic metabolic acidosis and extreme hypokalemia following prolonged vomiting and high-output fluid loss through a Bricker ureteroileocutaneostomy. The patient was admitted to the intensive care unit in a peri-arrest condition, where cardiac arrest occurred shortly thereafter. The monitored rhythm was ventricular fibrillation alternating with "torsade de pointes" ventricular fibrillation. During advanced life support, targeted high-dose intravenous potassium replacement, magnesium sulfate administration, and bicarbonate substitution were performed. A total of 120 mL of 7.4% potassium chloride was administered during resuscitation, resulting in return of spontaneous circulation after approximately 18 minutes. During the first 24 hours, a total of 460 mmol potassium chloride replacement was required. Following the return of spontaneous circulation, intermittent hemodialysis was performed to correct severe metabolic acidosis. During subsequent intensive care treatment, sepsis and bilateral pneumonia developed; however, with targeted antimicrobial therapy, organ support, and continuous electrolyte correction, the patient's condition gradually improved. Successful extubation was performed on day 7, and the patient was transferred back to the nephrology ward with favourable neurological outcome. This case highlights that rapidly developing severe hypokalaemia and metabolic acidosis in patients with Bricker urinary diversion may lead to malignant arrhythmias and cardiac arrest; however, prompt recognition of reversible metabolic abnormalities and aggressive targeted potassium replacement can be life-saving. Orv Hetil. 2026; 167(41): 1664-1668. |
Orvosi hetilap | 2026 Oct 11 | PubMed |
| 09 |
Pulmonary Artery Approach for Radiofrequency Catheter Ablation of Atrial Tachycardia Originating From Left Atrial Post Wall: A Case Report.
View abstractINTRODUCTION: Due to limitations in ablation energy delivery and myocardial wall thickness, endocardial ablation of atrial tachycardia can sometimes be challenging. METHODS AND RESULTS: In this case, ablation of the left atrial posterior wall shifted the earliest endocardial breakthrough site from the posterior wall to the roof, suggesting a potential epicardial origin near left atrial roof. The atrial arrhythmia was successfully eliminated via a right pulmonary artery approach. CONCLUSION: The right pulmonary artery approach may be an effective strategy for ablating epicardial atrial arrhythmias, particularly those originating from the left atrial posterior roof. |
Journal of cardiovascular electrophysiology | 2026 Oct 11 | PubMed |
| 10 |
Validation of a Revised V-Slope Algorithm for Automated First Ventilatory Threshold Detection in Healthy Adults.
View abstractBACKGROUND AND OBJECTIVES: The first ventilatory threshold (VT1) is a key indicator of submaximal aerobic fitness. Its determination typically relies on visual assessment, which is time-consuming and subject to interobserver variability. Automated solutions may offer a more objective, reproducible and time-efficient alternative. This study evaluated the accuracy of a revised V-slope method. METHODS: This retrospective study was conducted at University Hospitals Leuven, Belgium, using cardiopulmonary exercise test (CPET) data of 271 healthy adults collected between 2010 and 2020. Automated VT1 detection using a revised V-slope algorithm was compared with manual determination via the visual V-slope method in 262 participants with a determinable VT1. Agreement was evaluated using Bland-Altman analysis, intraclass correlation coefficients (ICC), Deming regression and equivalence testing (TOST). Interobserver agreement was evaluated using ICC. RESULTS: Median oxygen uptake at VT1 was higher with automated compared to manual assessment (1151 vs. 1122 mL/min; p < 0.001). Mean difference was 29 mL/min (95% CI [19, 40]. Relative mean bias was 2.2% ± 7.1% (LoA [- 11.7 to 16.0%], with excellent agreement (ICC 0.97 [95% CI 0.96-0.98] and a Deming regression slope of 0.95 [95% CI 0.92-0.99] and intercept of 26.1 mL/min [95% CI -11.9 to 64.7]. TOST with equivalence bounds [- 100, 100] was significant (p < 0.001; 90% CI [20, 38]). CONCLUSION: The revised V-slope algorithm demonstrated strong group-level agreement with visual assessment for VT1 determination, supporting the reliability and practical applicability for large-scale research applications in healthy adults. However, given the observed individual-level variability, caution is warranted when applying automated VT1 values to guide exercise prescription for individual patients without expert review. |
Sports medicine - open | 2026 Oct 11 | PubMed |
| 11 |
Surgical Ligation for Partial Anomalous Pulmonary Venous Connection With Dual Drainage in an Elderly Patient.
View abstractBACKGROUND: Partial anomalous pulmonary venous connection with dual drainage into both the superior vena cava (SVC) and left atrium (LA) is a rare congenital anomaly, with few reported cases. CASE SUMMARY: A 78-year-old woman presented with exertional dyspnea. Cardiac computed tomography revealed that the right pulmonary vein drained into both the SVC and LA, resulting in a significant left-to-right shunt. We ligated the anomalous connection with a median sternotomy. This approach allowed avoidance of complex reconstructions and cardioplegic arrest. DISCUSSION: Simple ligation may represent a less invasive surgical option that avoids cardiac arrest and shortens operative time. Moreover, it may prevent pulmonary venous obstruction and future heart failure caused by right heart volume overload. TAKE-HOME MESSAGE: In elderly patients with heart failure caused by partial anomalous pulmonary venous connection with dual drainage into both the SVC and LA, ligation of the left-to-right shunt may be less invasive and prevent late complications. |
JACC. Case reports | 2026 Oct 10 | PubMed |
| 12 |
Interventions addressing moral distress among nurses: A systematic review.
View abstractBackgroundNurses frequently encounter ethical dilemmas that, when they are unable to act in accordance with perceived ethical standards, may lead to moral distress. Moral distress is associated with a wide range of adverse psychological, physical, and professional outcomes, and its development is influenced by multiple individual, team-related, and organizational factors. Although various interventions have been proposed to reduce moral distress, the existing evidence regarding their effectiveness remains fragmented and heterogeneous.Research question/aim/objectivesThis systematic review aimed to identify, synthesize, and evaluate evidence on interventions designed to address moral distress in nurses across various clinical settings.Research designA systematic review study.Search and quality appraisalA comprehensive systematic search was conducted in major databases using a PICO-based strategy with no time restrictions, alongside citation tracking and manual searching to ensure completeness. Study selection followed Preferred Reporting Items for Systematic reviews and Meta-Analyses 2020 (PRISMA), and risk of bias and certainty of the evidence were assessed independently by three reviewers using Joanna Briggs Institute (JBI) tools and the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) framework.Findings/resultsThis review synthesized evidence from 29 studies conducted in various countries and clinical contexts, focusing on interventions designed to reduce moral distress among nurses. The majority of studies, especially those based on educational, cognitive-behavioral, and communication-oriented strategies, indicated a decrease in moral distress alongside improvements in associated professional and psychological outcomes.ConclusionsThis systematic review suggests that educational and skill-based interventions may reduce nurses' moral distress, particularly in the short term. However, the certainty of evidence is low due to methodological limitations and heterogeneity, and more rigorous, large-scale studies with longer follow-up are needed to confirm their effectiveness and sustainability. |
Nursing ethics | 2026 Oct 11 | PubMed |
| 13 | The chicken or the egg? Unravelling the role of vascular remodelling in HFpEF. | The Journal of physiology | 2026 Oct 11 | PubMed |
| 14 |
Rupture of Left Ventricular Aneurysm in Infant: Case Report.
View abstractRupture of ventricular aneurysm is an unusual pathology in children. This case describes a preterm infant who had been in the hospital since birth due to necrotizing enterocolitis, which was complicated by narrowing of the ascending colon that required surgery. Throughout the entire period, the infant exhibited signs of infection, first caused by and subsequently by . Several echocardiographic examinations did not reveal any significant changes; however, the final echocardiography revealed a structure connected to the left ventricular cavity. The infant experienced sudden cardiac arrest due to significant pericardial effusion. Despite continued resuscitation efforts, including emergency pericardiocentesis, the asystole recurred, further advanced life support measures were unsuccessful, and death was pronounced. Autopsy revealed a small outpouching on the anterior wall of the left ventricle, associated with thinning of the myocardium and a linear rupture with uneven edges. Histological examination showed that the aneurysm wall was composed of myocardium and connective tissue, exhibiting signs of inflammation, necrosis, and hemorrhage. |
International medical case reports journal | 2026 | PubMed |
| 15 |
Trends in Modifiable Risk Factors Contributing to Ischemic Heart Disease Mortality in Afghanistan: Estimates From the Global Burden of Disease Study 2023 (1999-2023).
View abstractBACKGROUND: Ischemic heart disease (IHD) is the leading cause of death, and the majority of this burden can be attributed to modifiable risk factors. Although surveys show that these risk factors are prevalent in Afghanistan, no study has used Global Burden of Disease (GBD) methodology to describe their contribution to IHD mortality. The study examined trends (1999-2023) in 14 selected behavioral, dietary, and metabolic risk factors for IHD mortality using the GBD 2023 estimates. METHODOLOGY: This retrospective analysis used GBD 2023 estimates of deaths from IHD in Afghanistan attributable to 14 selected behavioral, dietary, and metabolic risk factors and to the GBD "all risk factors" composite, which also includes exposures outside these 14 (e.g., air pollution), covering 1999-2023 (both sexes; all ages and age-standardized). The number (N) and percentage (%) attributable to each risk factor are reported. Trends in age-standardized death rates were examined with a segmented log-linear trend analysis written by the authors as a permutation-based approximation to the NCI Joinpoint approach; the NCI software was not used. The average annual percentage change (AAPC) and its 95% confidence interval (CI) are conditional on the selected model. A multiple linear regression was used only as a descriptive comparison of average rates by risk factor category, sex, and calendar year. A p-value of 0.05 or less was considered significant, with no adjustment for multiple comparisons, so the trend results are exploratory. RESULTS: From 1999 to 2023, the age-standardized IHD death rate for all GBD risk factors combined (the GBD composite) went down from 275.94 to 230.49 per 100,000. This is a drop of 16.5% (AAPC: -0.77%, 95% CI: -0.90 to -0.63; p < 0.001). We found at least one joinpoint in 41 of the 45 series, and most of them were around 2009 and 2013. High systolic blood pressure (11,969.1 deaths, or 55.17% of all IHD deaths in 2023) and high low-density lipoprotein (LDL) cholesterol (5,875.8 deaths, or 27.12%) remained the leading factors among the 14, both of which were decreasing (AAPC: -0.95% and -1.14%; both p < 0.001). The rates associated with a diet high in sugar-sweetened beverages (AAPC: +1.28%, 95% CI: +0.94 to +1.63; p < 0.001) and with smoking (AAPC: +0.37%; p < 0.001) increased, whereas the increases linked to a diet high in processed meat, sodium, and secondhand smoke were not significant in the segmented model (all p > 0.05). The age-standardized rates were higher among females, while the smoking rates were higher among males (25.83 as compared with 5.09 per 100,000). In the descriptive regression model (N = 700; R² = 0.963), average rates differed by risk factor category, calendar year, and sex (all p < 0.05), with high systolic blood pressure having the largest coefficient (B = +140.92; p < 0.001). CONCLUSIONS: In Afghanistan, metabolic risk factors, especially high systolic blood pressure and high LDL cholesterol, were the largest contributors to IHD deaths among the 14 selected risk factors. The composite age-standardized rate declined, with a common inflection around 2009-2013 that may reflect GBD modeling inputs. The rates attributable to sugar-sweetened beverages and to smoking increased, which points to an emerging threat that should be the subject of targeted prevention measures, with ongoing efforts to control hypertension and lipid levels. These exploratory trend estimates need confirmation with the NCI Joinpoint software. |
Cureus | 2026 Oct | PubMed |
| 16 |
ATRI LIMS: a cloud-native open-source laboratory information management system for biomarker-driven Alzheimer's disease clinical trials.
View abstractOBJECTIVES: This article summarizes the architecture, design principles, and implementation strategy of the ATRI Laboratory Information Management System (LIMS), a cloud‑native, open‑source platform supporting biomarker‑driven Alzheimer's disease (AD) clinical research. The system addresses challenges associated with managing large‑scale, multimodal biomarker, and biobanking data across multisite studies. METHODS: The ATRI LIMS employs a Model-View-Controller architecture implemented in Django, with Single‑Page Application interfaces built in ReactJS. A hybrid database model integrates a normalized core schema with study‑specific extensions. Deployment on Amazon Web Services incorporates multifactor authentication, encryption, and a web application firewall. Regulatory support is provided through audit trails and electronic signatures. Development relied on collaboration between informatics engineers and laboratory personnel, with user acceptance testing guiding workflow and interface refinement. RESULTS: As of February 2026, the ATRI LIMS supports seven clinical trials and observational studies and manages more than 1.2 million biospecimens. The platform synchronizes biospecimen metadata and assay outputs with clinical datasets, improves operational efficiency through automated workflows and quality control, and facilitates compliant sample sharing for secondary research. AI‑assisted development accelerated feature delivery while maintaining code quality. DISCUSSION: The ATRI LIMS offers a scalable, adaptable informatics framework for biomarker‑intensive AD research. Its modular design, cloud‑native architecture, and comprehensive data management capabilities support accurate specimen tracking and coordinated data integration. An open-source release is planned to enable adoption and adaptation by other research programs. CONCLUSIONS: The ATRI LIMS enhances informatics infrastructure for modern AD research by enabling scalable, efficient, and compliant biomarker and biospecimen workflow management. |
JAMIA open | 2026 Oct | PubMed |
| 17 |
Effectiveness of LDL Apheresis Techniques for Reducing LDL-C in Familial Hypercholesterolemia: A Systematic Review and Meta-Analysis.
View abstractOBJECTIVE: Familial hypercholesterolemia (FH) is a common inherited disorder characterized by markedly elevated low-density lipoprotein cholesterol (LDL-C) levels and an increased risk of premature cardiovascular disease. LDL apheresis is an extracorporeal procedure used to remove atherogenic lipoproteins from the circulation and is an established treatment option for selected patients with FH. This study aimed to systematically review and meta-analyze the effectiveness of different LDL apheresis techniques in reducing LDL-C and other lipid parameters in patients with FH. METHODS: A systematic review and meta-analysis was conducted on 9 March, 2025. PubMed/MEDLINE, Scopus, Web of Science Core Collection, EMBASE, and Google Scholar were searched using relevant keywords and Medical Subject Headings (MeSH) terms, without restrictions on publication date or publication status. Data were extracted and managed using EndNote and Microsoft Excel, and statistical analyses were performed using Stata 2017. The methodological quality of the included studies was assessed using appropriate Joanna Briggs Institute (JBI) critical appraisal checklists. Subgroup and sensitivity analyses were performed to explore potential differences according to study characteristics. Random-effects models were used to account for between-study heterogeneity. RESULTS: Of 1060 records identified through database and reference-list searches, 33 studies met the inclusion criteria. Germany contributed the largest number of included studies ( = 21). The pooled mean values following LDL apheresis were 163.40 mg/dL for total cholesterol (TC; 95% CI, 135.47-191.34; = 98.47%), 122.99 mg/dL for LDL-C (95% CI, 105.46-140.51; = 96.71%), 19.41 mg/dL for lipoprotein(a) [Lp(a)] (95% CI, 9.84-28.98; = 96.83%), and 7.06 mg/dL for high-density lipoprotein cholesterol (HDL-C) (95% CI, 5.24-8.89; = 80.87%). The pooled reduction in triglycerides (TG) was 46.94 mg/dL (95% CI, 32.88-60.99; = 98.47%). Among the evaluated techniques, double-filtration plasmapheresis (DFPP) showed the greatest reductions in TC, LDL-C, and HDL-C, with pooled reductions of 354.42, 281.82, and 15.75 mg/dL, respectively. No statistically significant differences among LDL apheresis techniques were observed for reductions in TG or Lp(a). Overall, the available evidence indicated reductions in these lipid parameters across the evaluated techniques, although substantial between-study heterogeneity was observed. CONCLUSION: LDL apheresis was associated with substantial reductions in TC, LDL-C, HDL-C, TG, and Lp(a) in patients with FH. The available evidence suggests that different LDL apheresis techniques have broadly comparable effects on TG and Lp(a), whereas DFPP demonstrated greater reductions in TC, LDL-C, and HDL-C in the available comparative evidence. However, the safety evidence should be interpreted cautiously because adverse events were not quantitatively synthesized and reporting varied across studies. Therefore, the available evidence does not permit definitive conclusions regarding the comparative safety of LDL apheresis techniques. In clinical practice, selection of a specific technique should consider treatment characteristics, patient tolerance, technical requirements, resource availability, and cost considerations in addition to lipid-lowering efficacy. |
Health science reports | 2026 Oct | PubMed |
| 18 |
External Iliac Arteriovenous Fistula Caused by Stab Wound.
View abstractMajor abdominal arteriovenous fistula (AVF), including external iliac vessels, is a rare condition. If untreated long term, AVFs may cause venous hypertension and heart failure. We report the case of a 47-year-old man who stabbed his left lower abdomen. His vital signs were stable. Computed tomography revealed hemoperitoneum and a left external iliac AVF. Prior to laparotomy, endovascular repair of AVF was performed. Subsequent laparotomy was performed, and omental injury and a small bowel injury were repaired. Exploration of the retroperitoneal hematoma showed no bleeding from the external iliac vessels. The patient was discharged on day 6. In the management of retroperitoneal hematoma after penetrating trauma, laparotomy has been recommended. Among hemodynamically stable patients with stab wounds and traumatic external iliac AVF, endovascular intervention may be considered prior to laparotomy. Further investigations are required to reveal the long-term safety and durability of a covered stent for traumatic AVFs. |
Clinical case reports | 2026 Oct | PubMed |
| 19 |
Postoperative Candida auris Bloodstream Infection Following Cardiac Surgery: Diagnostic Delay and Serial Changes in Azole MIC Values: A Case Report.
View abstractBACKGROUND: is an emerging multidrug-resistant fungal pathogen associated with healthcare-associated outbreaks and invasive infections, particularly in critically ill patients. Early recognition remains challenging due to nonspecific clinical presentations and overlap with bacterial infections. Postoperative bloodstream infection due to , especially following cardiac surgery, is still relatively uncommon and may be underrecognized in clinical practice. CASE PRESENTATION: A 69-year-old man developed persistent fever, dyspnea, and bilateral postoperative pulmonary infiltrates after modified Morrow surgery and bioprosthetic mitral valve replacement. The pulmonary findings were clinically diagnosed as severe pneumonia, although imaging was nonspecific and also raised the possibility of pulmonary edema or heart failure. Despite broad-spectrum anti-infective therapy, his condition did not improve. Three separate catheter-drawn blood cultures collected on 21, 24, and 28 July 2025 subsequently yielded , confirming candidemia. No respiratory specimen yielded ; therefore, the pulmonary abnormalities were considered concurrent with, rather than microbiologically attributable to, the bloodstream infection. Antifungal susceptibility testing showed persistently high fluconazole MICs, while itraconazole and voriconazole MICs increased in the third isolate. Because validated -specific clinical breakpoints were unavailable for these agents, the MIC findings were interpreted descriptively. Following adjustment of antifungal therapy and continued supportive care, the patient became afebrile, achieved clinical stabilization, and had a negative follow-up blood culture before discharge. CONCLUSION: This case highlights the diagnostic challenge of bloodstream infection in postoperative patients, where clinical features may mimic bacterial pneumonia. Persistent fever unresponsive to empirical antimicrobial therapy should prompt early consideration of invasive fungal infection. Timely microbiological diagnosis and appropriate antifungal treatment are essential for improving outcomes. Increased awareness of infection in surgical and hospitalized patients is critical for early recognition and effective management. |
Infection and drug resistance | 2026 | PubMed |
| 20 |
Physical Activity, Myokine-Adipokine Signatures and Haemoglobin Glycation Index in Adults with Type 2 Diabetes.
View abstractBACKGROUND: The Hemoglobin Glycation Index (HGI) reflects variability in hemoglobin glycation beyond ambient glycaemia and is a marker of metabolic heterogeneity, cardiovascular risk and treatment response in type 2 diabetes mellitus (T2DM). Whether circulating myokines and adipokines are related to HGI, or whether relationships differ across exercise modalities, is unclear. OBJECTIVE: To examine associations of circulating myokines (irisin, myostatin, myonectin, IL-6, IL-15) and adipokines (leptin, adiponectin) with HGI, and whether associations differ between physically active and sedentary individuals and across exercise modalities. METHODS: Cross-sectional study of 185 adults with T2DM recruited at Thumbay Hospital, Ajman, United Arab Emirates, classified as physically active (n=98) or sedentary (n=87), with active individuals sub-grouped by predominant modality: aerobic (70), resistance (11), combined (17). Measurements were obtained after an overnight fast. HGI was calculated as the residual of HbA1c regressed on fasting plasma glucose. Mann-Whitney U, Kruskal-Wallis, Spearman correlations with false discovery rate (FDR) correction and median regression adjusted for age, sex, BMI and fasting glucose were used. RESULTS: Active participants had lower HGI than sedentary participants (median -0.44 vs 0.12; p = 0.001), with lower BMI, fasting glucose and HbA1c. HGI differed by modality (p < 0.001), most favourable in the combined-training group and least favourable in the aerobic-only group. IL-6 was inversely correlated with HGI in active participants and leptin in sedentary participants (both FDR p < 0.05). Physical activity remained an independent predictor of lower HGI after adjustment for age, sex and BMI (β = -0.65;p< 0.001), and persisted after adjustment for IL-15 and leptin. CONCLUSION: Precludes causal inference; if confirmed prospectively, associations may inform individualized exercise prescription and HGI-based risk stratification.Distinct myokine-adipokine signatures were associated with glycation variability beyond mean glycaemia and combined aerobic-plus-resistance training with the most favourable HGI profile. The cross-sectional design precludes causal inference; if confirmed prospectively, associations may inform individualized exercise prescription and HGI-based risk stratification. |
Diabetes, metabolic syndrome and obesity : targets and therapy | 2026 | PubMed |
| 21 |
From Local Evidence to Regional Leadership: Post-Preeclampsia Care in Thailand.
View abstractHypertensive disorders of pregnancy, particularly preeclampsia, identify women at increased risk of persistent hypertension and later cardiovascular disease, yet postpartum services often remain organized around short-term obstetric recovery. Thailand is well positioned to address this discontinuity because prospective local studies have demonstrated elevated blood pressure, hypertension, and selected cardiovascular and renal risk markers at 6 weeks and 6-12 months after preeclampsia or gestational hypertension. The principal policy gap is therefore not the absence of warning evidence, but the lack of a standardized and auditable handover from maternity services to primary care and cardiovascular prevention. This commentary was informed by a targeted, non-systematic examination of peer-reviewed studies, international professional recommendations, World Health Organization resources, and publicly accessible national guidance available in English through June 2026. Evidence was selected to characterize longer-term cardiovascular and renal risk following hypertensive disorders of pregnancy, summarize relevant Thai postpartum findings, and identify regional health-system approaches that could inform continuity of care in Thailand. Vietnam, Malaysia, and Mongolia were purposively selected as complementary examples of community noncommunicable-disease integration, local-clinic follow-up after hypertensive pregnancy, and continuity of care across geographic distance, respectively. We propose a standardized multicenter pilot comprising documented risk communication and a named receiving provider before discharge; blood-pressure evaluation within 72 hours for women with severe hypertension and no later than 7-10 days for other women with hypertensive disorders; structured assessment at 6-12 weeks and 6-12 months; permanent recording of hypertensive pregnancy history; and annual cardiovascular-risk review. National scale-up should follow evaluation of feasibility, completion, equity, and clinical outcomes. The aim is not to create a parallel specialty service, but to convert an established obstetric warning sign into accountable long-term cardiovascular and renal prevention. |
International journal of women's health | 2026 | PubMed |
| 22 |
Traditional Chinese Medicine Modulation of Macrophage Polarization in Inflammation Associated with Coronary Heart Disease: Mechanisms and Challenges.
View abstractCoronary heart disease (CHD) remains a leading cause of global mortality, with unresolved inflammation constituting a major residual risk after conventional therapies. Macrophage polarization, characterized by shifts between pro-inflammatory M1 and reparative M2 phenotypes, influences vascular inflammation, plaque stability, myocardial injury, and tissue repair, making it a potential therapeutic target in CHD. Traditional Chinese Medicine (TCM) is increasingly recognized for its multi-target immunomodulatory properties. This review systematically synthesizes the current evidence on the mechanisms by which TCM formulas and active ingredients regulate macrophage polarization to modulate the inflammatory response in CHD. Importantly, the stage-specific roles of TCM during the progression of CHD (atherosclerosis, acute myocardial infarction, ischemia-reperfusion injury, and post-infarct repair) are delineated. Emerging mechanistic insights into metabolic reprogramming, mitochondrial function, and epigenetic modifications are also highlighted. However, most evidence linking TCM to macrophage polarization in CHD is derived from cellular and animal studies, while direct clinical validation remains limited. Finally, current limitations, knowledge gaps, and future directions for basic research and clinical translation are discussed. By moving beyond descriptive pathway enumeration to an integrated framework that encompasses signaling networks, disease-stage dynamics, and deep molecular mechanisms, this review aims to provide a comprehensive reference for investigators and clinicians interested in TCM-based immunomodulatory strategies for CHD. |
Journal of inflammation research | 2026 | PubMed |
| 23 |
Rheumatic Heart Disease Burden and Sex Differences in China and ASEAN Countries, 1990-2030: A Comparative Analysis from the Global Burden of Disease Study 2023.
View abstractBACKGROUND: Rheumatic heart disease (RHD) remains a major public health concern in low‑ and middle‑income countries. Systematic comparisons between China and the ten ASEAN member states examining sex disparities are scarce. METHODS: Using Global Burden of Disease Study 2023 data, we analyzed RHD burden in China and ten ASEAN countries from 1990 to 2023. Key measures included age‑standardized prevalence (ASPR), mortality (ASMR), and disability‑adjusted life‑years rates (ASDR). Temporal trends were assessed via estimated annual percentage changes (EAPCs) and joinpoint regression. Decomposition analysis quantified contributions of population aging, growth, and epidemiological change. Age‑period‑cohort modeling and ARIMA forecasting (2024‑2030) were applied. RESULTS: From 1990 to 2023, China achieved steeper declines in ASDR (EAPC: -7.03 vs -2.40) and ASMR (-7.07 vs -2.87) than ASEAN. In 2023, Cambodia, Myanmar, and Laos had the highest burdens; Singapore, Brunei, and Thailand were comparable to China. Females consistently had higher rates than males across all indicators, with wider sex disparity in ASEAN (female‑to‑male ASDR ratio 1.6 vs 1.1 in China). Decomposition analysis showed that China's female DALY decline was driven by epidemiological improvement (189.7%), whereas in ASEAN population growth largely offset gains (-145.9%). Joinpoint analysis revealed that China's female ASDR and ASMR plateaued after 2020, while ASEAN's female ASPR increased in 2021-2023 (APC: 0.22). Projections suggested that by 2030 China's female ASMR would fall below the ASEAN average, potentially positioning China as a regional low‑burden benchmark for all three female indicators. CONCLUSION: China has made remarkable progress in reducing female RHD burden, outpacing ASEAN. However, the observed post‑2020 plateau in China and the recent rise in female prevalence in ASEAN demand renewed efforts. Persistent sex disparities underscore the urgent need for targeted secondary prophylaxis and regional cooperation, particularly for women of childbearing age in high‑burden countries. |
International journal of women's health | 2026 | PubMed |
| 24 |
Probing Red Blood Cell Deformability in Sickle Cell Disease, Sickle Cell Trait, and Healthy Controls by Ektacytometry.
View abstractINTRODUCTION: Red blood cell (RBC) deformability is a key determinant of sickle cell disease (SCD) pathophysiology. We evaluated RBC deformability across HbSS, HbAS, and HbAA genotypes and investigated its associations with hemolysis, fetal hemoglobin (HbF), coinherited α-thalassemia, hydroxyurea treatment, and the E756del variant. METHODS: We used Lorrca ektacytometry to compare RBC deformability across 174 participants with HbSS, HbAS, and HbAA genotypes. Deformability was evaluated across a range of shear stresses, osmotic pressures, and oxygen tensions. Associations between deformability and hemolysis markers, HbF levels, α-thalassemia status, hydroxyurea use, and the E756del variant were assessed. RESULTS: HbSS RBCs showed markedly reduced deformability across all shear stresses, osmotic pressures, and oxygen tensions compared to HbAS and HbAA RBCs. Reduced deformability correlated with elevated markers of hemolysis, including lactate dehydrogenase (LDH) and bilirubin. Higher HbF levels were independently associated with improved RBC deformability, whereas coinherited α-thalassemia was not associated with improved deformability. Hydroxyurea use was associated with significantly improved deformability. The E756del variant was associated with reduced deformability among participants with HbSS. CONCLUSION: RBC deformability is substantially impaired in HbSS and is associated with markers of hemolysis and several genetic and treatment-related factors. These findings support Lorrca ektacytometry as a robust biomarker platform for assessing RBC health and treatment response in SCD. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT03685721. |
EJHaem | 2026 Oct | PubMed |
| 25 |
Identifying Differentially Expressed Proteins via Plasma Exosomal Proteomics.
View abstractExtracellular vesicle (EV) proteomics can be used to study intercellular communication and find biomarkers of non-invasive diseases. Traditional separation methods (ultracentrifugation, size exclusion chromatography) and data-dependent acquisition (DDA) mass spectrometry usually have the drawbacks of copurification of pollutants, poor reproducibility, and insufficient sampling of low-abundance peptides. This protocol describes a workflow for label-free extracellular vesicle proteomics, which combines size exclusion chromatography for vesicle separation, data-independent acquisition (DIA) for deep discovery, and parallel reaction monitoring (PRM) for targeted verification. Plasma-derived extracellular vesicles are treated by standardized lysis, digestion, and LC-MS/MS procedures, so that the protein group of extracellular vesicles can be identified and quantified robustly. The main advantages of this scheme are that it can achieve high quantitative reproducibility, unbiased detection of low-intensity peptides, and seamless transition from discovery to targeted verification, while also being suitable for liquid biopsy samples and various cardiovascular diseases. Key features • Combines size exclusion chromatography (SEC)-based EV isolation with label-free data-independent acquisition (DIA) for deep, unbiased discovery-phase extracellular vesicle proteomics. • Employs parallel reaction monitoring (PRM) for orthogonal, highly sensitive targeted validation of candidate biomarkers discovered by DIA. • PRM records the entire, high-resolution fragment ion spectrum for the targeted peptide. • Developed for atrial fibrillation; adaptable to other cardiovascular diseases, therapy monitoring, and liquid biopsies. |
Bio-protocol | 2026 Oct 5 | PubMed |

